Wouldn't they just continue to negotiate. Why the CRL if it was just labeling? Pfizer is still negotiating labeling, but they haven't received CRL (unless I am forgetting). I think it is something more. I wonder if they think data was too good and want larger study to be done.
The data was build on a cushion of bs. Notice the palpable absence of all the positive notions of past?????
Should have noted the hire of another expert (FDA guy) who apparently only knows how to take a salary and compensation for doing nothing. Same as for NH himself.
Greatest compliments to all who preached approval, even earlier approval. There should be a joined tap dance with NH. I honestly believe investors need more from NH besides his "oh well" statement.
News 
Market Data 
Discover 
